For Black women, the decision echoes a history of employers imposing their religious beliefs on our reproductive freedom.
The Hobby Lobby case is not some odd outlier regarding “religious freedom.” It’s just one of the many ways the anti-choice movement is trying to chip away at women’s access to contraception and instill the idea in the public’s mind that contraception is controversial.
Colorado GOP senatorial candidate Cory Gardner proposed on Thursday that oral contraception be available for over-the-counter purchase. Critics point out that Gardner’s position runs counter to his record of votes in favor of restricting access to contraception.
Twitter’s confusing ad policies stifle the promotion of basic, vitally important health products such as condoms.
While Twitter doesn’t technically prohibit condom ads, it does prohibit advertising for unspecified forms of “contraceptives,” which could keep groups from spreading information about sexual health.
Rick Santorum recently made remarks suggesting that he’d prefer having everyone’s contraception covered by the government instead of by insurance plans. That might seem like a good idea on its surface, but in reality it would reduce access to contraception.
Despite the fact that IUDs and other forms of contraception prevent pregnancy from occurring, and therefore cannot cause an abortion, Saline County Commissioner John Price said during a meeting Tuesday, “I think it is murder to take this [grant money]. To me it is murder, and I am not standing for it.”
Recently, social media lit up with the news that Amazon.com vendors are selling Plan B One-Step emergency contraception for as low as $16.90 plus shipping. We have to ask: How is that possible?
On this episode of Reality Cast, I talk to a playwright who went undercover in the anti-choice movement. Also, I cover how conservatives continue to test new attacks on contraception access, and the Donald Sterling drama reminds us that HIV stigma is still a very real problem.
Though the FDA decision to permit generic EC pill manufacturers to sell their products over the counter represents a gain for those with the most access to resources, ultimately the decision reflects pharmaceutical manufacturing companies’ interests, rather than the lives of those most adversely affected by lack of access to EC.